SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-017308
Filing Date
2023-11-02
Accepted
2023-11-02 06:35:12
Documents
15
Period of Report
2023-11-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K imgn-20231102x8k.htm   iXBRL 8-K 36420
2 EX-99.1 imgn-20231102xex99d1.htm EX-99.1 200127
  Complete submission text file 0001558370-23-017308.txt   465310

Data Files

Seq Description Document Type Size
3 EX-101.SCH imgn-20231102.xsd EX-101.SCH 4366
4 EX-101.DEF imgn-20231102_def.xml EX-101.DEF 3239
5 EX-101.LAB imgn-20231102_lab.xml EX-101.LAB 635
6 EX-101.PRE imgn-20231102_pre.xml EX-101.PRE 10105
9 EXTRACTED XBRL INSTANCE DOCUMENT imgn-20231102x8k_htm.xml XML 4636
Mailing Address 830 WINTER ST WALTHAM MA 02451
Business Address 830 WINTER ST WALTHAM MA 02451 (781)895-0600
ImmunoGen, Inc. (Filer) CIK: 0000855654 (see all company filings)

IRS No.: 042726691 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-17999 | Film No.: 231369923
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences